miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1

Oncology Letters
Xiangjun LiuXiaohui Xu

Abstract

Osteosarcoma is a common bone tumor and a frequently occuring cancer-associated threat to children. Notably, the prognosis of osteosarcoma is very poor when it is diagnosed with metastasis. A growing number of studies have indicated that various microRNAs (miRs) serve important regulatory roles in the pathogeny of different types of cancer. However, the functions of miR-210 in osteosarcoma need to be elucidated comprehensively. The aim of the present study was to investigate the potential roles of miR-210 in osteosarcoma by targeting fibroblast growth factor receptor-like 1 (FGFRL1). Reverse transcription-quantitative polymerase chain reaction results revealed that the expression of miR-210 was highly elevated while FGFRL1 expression was reduced inversely in osteosarcoma tissues compared with matched normal tissues. The results of Transwell assays showed that miR-210 promoted osteosarcoma cell migration and invasion. Furthermore, the luciferase reporter assay results suggested that miR-210 could directly bind to FGFRL1 in osteosarcoma cells. In addition, the present findings demonstrated that miR-210 could negatively regulate FGFRL1 expression by targeting the 3'untranslated region. In conclusion, the findings of the present st...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Aug 8, 2008·Bioinformation·Jayapal ManikandanPeter Natesan Pushparaj
Feb 28, 2009·Nature Reviews. Drug Discovery·Andrew Beenken, Moosa Mohammadi
May 30, 2009·Journal of Cellular Biochemistry·Kai RuanGaoliang Ouyang
Jan 14, 2010·Molecular Cancer·Masataka HirotsuSetsuro Komiya
Nov 17, 2010·Cellular and Molecular Life Sciences : CMLS·Beat Trueb
Oct 12, 2013·Antioxidants & Redox Signaling·Harriet E GeeMircea Ivan
Jun 10, 2014·Journal of Experimental & Clinical Cancer Research : CR·Qin QinLi Baosheng
Aug 26, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S IsakoffRichard Gorlick
Oct 30, 2015·Expert Opinion on Pharmacotherapy·Stefano Ferrari, Massimo Serra
May 26, 2016·International Journal of Molecular Medicine·Xiaochen YangBeat Trueb
Jul 28, 2016·Cancer Biology & Medicine·Wen-Ya ZhouJi-Long Yang
Dec 7, 2016·British Journal of Biomedical Science·BoLin SunZhenLing Dong
Jan 8, 2017·Journal of Hematology & Oncology·Pablo AnguloShrikant Anant
Jul 1, 2017·Bioscience, Biotechnology, and Biochemistry·Hongying DiaoZhuoran Li
Jul 4, 2017·Journal of Cellular Physiology·Enrica UrciuoliBarbara Peruzzi
Oct 8, 2017·Biochemical and Biophysical Research Communications·Zhengwen SunTongqing Zhang
Nov 9, 2017·Oncology Letters·Dongqi WangZhan Wang

❮ Previous
Next ❯

Citations

Apr 6, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G M VieraM S Brassesco

❮ Previous
Next ❯

Methods Mentioned

BETA
Transfection
transfections
surgical resection

Software Mentioned

SPSS
Target Scan

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.